In-vitro, in-vivo and ex-vivo studies with oral β-lactams against Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 6, 1998, Pages 629-634

  Pérez Trallero, Emilio ^a   Alkorta, Mirian ^a   García Arenzana, José M ^a   Iturzaeta, Ana ^a   Gomariz, Maria ^a  

^a Hospital Nuestra Senora de Aranzazu   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFPODOXIME PROXETIL; CEFUROXIME AXETIL; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PENICILLIN RESISTANCE; RANDOMIZED CONTROLLED TRIAL; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADMINISTRATION, ORAL; ADULT; AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CEFTIZOXIME; CEFUROXIME; CEPHALOSPORINS; EVALUATION STUDIES; FEMALE; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; RANDOM ALLOCATION; SERUM BACTERICIDAL TEST; STREPTOCOCCUS PNEUMONIAE;

EID: 0031842018     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.6.629     Document Type: Article

References (22)

1. Greenwood, D. (1981). In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. Journal of Infectious Diseases 144, 380-5.
2. Nightingale, J. (1987). Clinical limitations of in vitro testing of microorganism susceptibility. American Journal of Hospital Pharmacy 44, 131-7.
3. Drusano, G. L. (1988). Role of pharmacokinetics in the outcome of infections. Antimicrobial Agents and Chemotherapy 32, 289-97.
4. Mattie, H. (1981). Kinetics of antimicrobial action. Reviews in Infectious Diseases 3, 19-27.
5. Liñares, J., Alonso, T., Perez, J. L., Ayats, J., Dominguez, M. A., Pallares, R. et al. (1992). Decreased susceptibility of penicillinresistant pneumococci to twenty-four (beta)-lactam antibiotics. Journal of Antimicrobial Chemotherapy 30, 279-88.
6. Spangler, S. K., Jacobs, M. R. & Appelbaum, P. C. (1994). In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin/ clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime and cefdinir. Antimicrobial Agents and Chemotherapy 38, 2902-4.
7. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria Which Grow Aerobically. Fourth edition. Approved Standard M7-A4. NCCLS, Villanova, PA.
8. National Committee for Clinical Laboratory Standards. (1992). Methods for Determining Bactericidal Activity of Antimicrobial Agents: Tentative Guideline M26-T. NCCLS, Villanova, PA.
9. Hindler, J. (1992). Serum Inhibitory and Bactericidal Titers. In Clinical Microbiology Procedures (Isenberg, H. D., Ed.), pp. 5.17.1-19. American Society of Microbiology, Washington, DC.
10. Nelson, C. T., Mason, E. O. & Kaplan, S. L. (1994). Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatric Infectious Diseases Journal 13, 585-9.
11. Briceland, L. L., Pasko, M. T. & Mylotte, J. M. (1987). Serum bactericidal rate as a measure of antibiotic interactions. Antimicrobial Agents and Chemotherapy 31, 679-85.
12. Amsterdam, D. (1996). Susceptibility testing of antimicrobials in liquid media. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 52-111. Williams & Wilkins, Baltimore, MD.
13. O'Reilly, T., Cleeland, R. & Squires, E. L. (1996). Evaluation of antimicrobials in experimental animal infections. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 604-765. Williams & Wilkins, Baltimore, MD.
14. Johnson, C. C. (1996). In vitro testing: correlations between bacterial susceptibility, body fluid levels and effectiveness of antibacterial therapy. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 813-34. Williams & Wilkins, Baltimore, MD.
15. Onyeji, C. O., Nicolau, D. P., Nightingale, C. H. & Quintiliani, R. (1994). Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections. Antimicrobial Agents and Chemotherapy 38, 1112-7.
16. Soriano, F., Ponte, C., Nieto, E. & Parra, A. (1996). Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumonia. Journal of Antimicrobial Chemotherapy 38, 227-36.
17. Soriano, F., García-Corbeira, P., Ponte, C., Fernández-Roblas, R. & Gadea, I. (1996). Correlation of pharmacodynamic parameters of five β-lactam antibiotics with therapeutic efficacies in an animal model. Antimicrobial Agents and Chemotherapy 40, 2686-90.
18. Drusano, G., Standiford, H., Ryan, P., McNamee, W., Tatem, B. & Schimpff, S. (1986). Correlation of predicted serum bactericidal activities and values measured in volunteers. European Journal of Clinical Microbiology 5, 88-92.
19. Klastersky, J., Daneau, D., Swings, G. & Weenrts, D. (1974). Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. Journal of Infectious Diseases 129, 187-93.
20. Balcabao, I. P., Aguilar, L., Martín, M., García, Y., Dal-Ré, R. & Prieto, J. (1996). Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation. Antimicrobial Agents and Chemotherapy 40, 2904-6.
21. Sauve, C., Azoulay-Dupuis, E., Moine, P., Darras-Joly, C., Rieux, V., Carbon, C. et al. (1996). Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 40, 2829-34.
22. Aguilar, L., Rosendo, J., Balcabao, I. P., Martin, M., Gimenez, M. J., Frías, J. & Prieto, J. (1997). Pharmacodynamic effects of amoxillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: A phase I study. Antimicrobial Agents and Chemotherapy 41, 1389-91.